• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Indutrade makes add-on acquisition within Life Science

Indutrade

Indutrade has signed an agreement to acquire all shares in the German company PHACOTEC Produkt-Service GmbH, www.phacotec.de, with annual sales of approximately EUR 2.7 million (SEK 30 million).

Phacotec is specialised in packaging materials and primary packaging solutions for the pharmaceutical and food industries. The company has an extensive customer base and offers a broad range of containers, closures and related packaging components from both proprietary and established industry brands. Phacotec was founded in 1998, has three employees and is located in Hamburg, Germany.

As an add-on to Indutrade-owned APG Europe in the Netherlands, the companies’ combined offerings will provide good growth opportunities.

The closing took place on 22 May and Phacotec will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's fourth in 2026 and is expected to have a marginally positive impact on Indutrade's earnings per share.

For further information, please contact:
Bo Annvik, President and CEO
Phone +46 8 703 03 00

About Indutrade
Indutrade is an international technology and industrial business group that today consists of over 220 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 32.2 billion in 2025, and the share is listed on Nasdaq Stockholm in Sweden.

Attachments
Indutrade makes add-on acquisition within Life Science